These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8822348)

  • 1. The effect of systemically administered PDGF-BB on the rodent skeleton.
    Mitlak BH; Finkelman RD; Hill EL; Li J; Martin B; Smith T; D'Andrea M; Antoniades HN; Lynch SE
    J Bone Miner Res; 1996 Feb; 11(2):238-47. PubMed ID: 8822348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
    Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats.
    Marie PJ; Hott M; Modrowski D; De Pollak C; Guillemain J; Deloffre P; Tsouderos Y
    J Bone Miner Res; 1993 May; 8(5):607-15. PubMed ID: 8511988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of an effect of sodium zeolite A on rat tibia histomorphometry.
    Firling CE; Evans GL; Wakley GK; Sibonga J; Turner RT
    J Bone Miner Res; 1996 Feb; 11(2):254-63. PubMed ID: 8822350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term changes in bone mineral and biomechanical properties of vertebrae and femur in aging, dietary calcium restricted, and/or estrogen-deprived/-replaced rats.
    Jiang Y; Zhao J; Genant HK; Dequeker J; Geusens P
    J Bone Miner Res; 1997 May; 12(5):820-31. PubMed ID: 9144349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived growth factor enhances bone cell replication, but not differentiated function of osteoblasts.
    Hock JM; Canalis E
    Endocrinology; 1994 Mar; 134(3):1423-8. PubMed ID: 8119182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.
    Ma YL; Bryant HU; Zeng Q; Schmidt A; Hoover J; Cole HW; Yao W; Jee WS; Sato M
    Endocrinology; 2003 May; 144(5):2008-15. PubMed ID: 12697709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
    J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.
    Fuchs RK; Shea M; Durski SL; Winters-Stone KM; Widrick J; Snow CM
    Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of an osteoconductive anorganic bovine bone mineral matrix with growth factors.
    Jiang D; Dziak R; Lynch SE; Stephan EB
    J Periodontol; 1999 Aug; 70(8):834-9. PubMed ID: 10476889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel EP4 receptor agonist-bisphosphonate conjugate drug (C1) promotes bone formation and improves vertebral mechanical properties in the ovariectomized rat model of postmenopausal bone loss.
    Liu CC; Hu S; Chen G; Georgiou J; Arns S; Kumar NS; Young RN; Grynpas MD
    J Bone Miner Res; 2015 Apr; 30(4):670-80. PubMed ID: 25284325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable beta-tricalcium phosphate/collagen matrix.
    Hollinger JO; Onikepe AO; MacKrell J; Einhorn T; Bradica G; Lynch S; Hart CE
    J Orthop Res; 2008 Jan; 26(1):83-90. PubMed ID: 17676626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease.
    Howell TH; Fiorellini JP; Paquette DW; Offenbacher S; Giannobile WV; Lynch SE
    J Periodontol; 1997 Dec; 68(12):1186-93. PubMed ID: 9444594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual-energy X-ray absorptiometric and histomorphometric study.
    Chen HK; Ke HZ; Jee WS; Ma YF; Pirie CM; Simmons HA; Thompson DD
    J Bone Miner Res; 1995 Aug; 10(8):1256-62. PubMed ID: 8585430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of hyaluronan on bone resorption and bone mineral density in a rat model of estrogen deficiency-induced osteopenia.
    Stancíková M; Svík K; Istok R; Rovenský J; Velebný V
    Int J Tissue React; 2004; 26(1-2):9-16. PubMed ID: 15573687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats.
    Tivesten A; Movérare-Skrtic S; Chagin A; Venken K; Salmon P; Vanderschueren D; Sävendahl L; Holmäng A; Ohlsson C
    J Bone Miner Res; 2004 Nov; 19(11):1833-9. PubMed ID: 15476584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.